Treatment with echinocandins during continuous renal replacement therapy

被引:0
作者
Francisco Javier González de Molina
MariadeLosÁngeles Martínez-Alberici
Ricard Ferrer
机构
[1] Hospital Universitari Mútua de Terrassa,Intensive Care Department
[2] Universitat de Barcelona,undefined
[3] Plaça Dr. Robert,undefined
来源
Critical Care | / 18卷
关键词
Acute Kidney Injury; Continuous Renal Replacement Therapy; Caspofungin; Invasive Candidiasis; Micafungin;
D O I
暂无
中图分类号
学科分类号
摘要
Echinocandins are indicated as first-line treatment for invasive candidiasis in moderate to severe illness. As sepsis is the main cause of acute kidney injury, the combination of echinocandin treatment and continuous renal replacement therapy (CRRT) is common. Optimizing antibiotic dosage in critically ill patients receiving CRRT is challenging. The pharmacokinetics of echinocandins have been studied under various clinical conditions; however, data for CRRT patients are scarce. Classically, drugs like echinocandins with high protein binding and predominantly non-renal elimination are not removed by CRRT, indicating that no dosage adjustment is required. However, recent studies report different proportions of echinocandins lost by filter adsorption. Nevertheless, the clinical significance of these findings remains unclear.
引用
收藏
相关论文
共 50 条
[31]   Edoxaban pharmacokinetics during in vitro continuous renal replacement therapy [J].
Wenzler, Eric ;
Dalton, Kaitlyn ;
Andrews, Lauren ;
Benken, Scott T. .
BMC NEPHROLOGY, 2024, 25 (01)
[32]   Incidence of Adverse Events during Continuous Renal Replacement Therapy [J].
Akhoundi, Abbasali ;
Singh, Balwinder ;
Vela, Myriam ;
Chaudhary, Sanjay ;
Monaghan, Myles ;
Wilson, Gregory A. ;
Dillon, John J. ;
Cartin-Ceba, Rodrigo ;
Lieske, John C. ;
Gajic, Ognjen ;
Kashani, Kianoush .
BLOOD PURIFICATION, 2015, 39 (04) :333-339
[33]   β-lactam antibiotic concentrations during continuous renal replacement therapy [J].
Marjorie Beumier ;
Giuseppe Stefano Casu ;
Maya Hites ;
Lucie Seyler ;
Frederic Cotton ;
Jean-Louis Vincent ;
Frédérique Jacobs ;
Fabio Silvio Taccone .
Critical Care, 18
[34]   Recovery of renal function and survival after continuous renal replacement therapy during extracorporeal membrane oxygenation [J].
Paden, Matthew L. ;
Warshaw, Barry L. ;
Heard, Micheal L. ;
Fortenberry, James D. .
PEDIATRIC CRITICAL CARE MEDICINE, 2011, 12 (02) :153-158
[35]   Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure [J].
Chua, Horng-Ruey ;
Baldwin, Ian ;
Bailey, Michael ;
Subramaniam, Ashwin ;
Bellomo, Rinaldo .
JOURNAL OF CRITICAL CARE, 2012, 27 (06)
[36]   A hypothesis on treatment strategy of severe multicentric Castleman disease with continuous renal replacement therapy [J].
Constantinescu, Catalin ;
Kegyes, David ;
Tigu, Bogdan ;
Moisoiu, Vlad ;
Grajdieru, Olga ;
Szekely, Andrea ;
Terpos, Evangelos ;
Tomuleasa, Ciprian .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (17)
[37]   Nafamostat mesilate for anticoagulation in continuous renal replacement therapy [J].
Hwang, Seun Deuk ;
Hyun, Yu Kyung ;
Moon, Sung Jin ;
Lee, Sang Choel ;
Yoon, Soo Young .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2013, 36 (03) :208-216
[38]   Precision Fluid Management in Continuous Renal Replacement Therapy [J].
Murugan, Raghavan ;
Hoste, Eric ;
Mehta, Ravindra L. ;
Samoni, Sara ;
Ding, Xiaoqiang ;
Rosner, Mitchell H. ;
Kellum, John A. ;
Ronco, Claudio .
BLOOD PURIFICATION, 2016, 42 (03) :266-278
[39]   Regional citrate anticoagulation for continuous renal replacement therapy [J].
Kindgen-Milles, Detlef ;
Brandenburger, Timo ;
Dimski, Thomas .
CURRENT OPINION IN CRITICAL CARE, 2018, 24 (06) :450-454
[40]   Patient Selection and Timing of Continuous Renal Replacement Therapy [J].
Ostermann, Marlies ;
Joannidis, Michael ;
Pani, Antonello ;
Floris, Matteo ;
De Rosa, Silvia ;
Kellum, John A. ;
Ronco, Claudio .
BLOOD PURIFICATION, 2016, 42 (03) :224-237